Drugs / Pneumovax II
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01432158 | Jan → Aug 2012 | pneumococcal infection | University of Oxford | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pneumovax-II | “The purpose of this trial is to investigate in detail the kinetics of the immune response to Prevenar-13, a pneumococcal conjugate vaccine, compared to Pneumovax-II, a...” NCT01432158 ↗ |
| Modality | Vaccine | “Pneumovax-II, a pneumococcal plain polysaccharide vaccine” NCT01432158 ↗ |